Similar observations were seen with RTOG 9402 and EORTC 26951 studies that looked at patients with IDH mutant high-grade gliomas and tumors formerly known as anaplastic oligodendrogliomas (grade 3). This evidence concerns the gene IDH2 and central nervous system cancer.